CLEVELAND Semaglutide, which is a popular drug used to treat diabetes, could soon have another use
Even if a patient qualifies, navigating insurance approvals can take months
For GLP-1 drugs, the risks include: Increased anxiety or panic from unstable blood sugar Triggering or worsening depression Heightened risk of obsessive eating behaviors Potential for self-esteem issues or body image dysmorphia For someone already struggling with mental health, these risks are compounded making proper medical oversight essential
Our programs feature both Semaglutide , known for its powerful effects on appetite, and Tirzepatide , a dual-action medication offering enhanced benefits for many patients
As explained above, rapid weight loss, nutritional deficiency, and immune system changes can cause more hairs to shed
Last week, the FDA accused Novo Nordisk of failing to develop proper procedures for reporting on side effects related to these popular diabetes and weight loss drugs